RNfinity
Research Infinity Logo, Orange eye of horus, white eye of Ra
  • Home
  • Submit
    Research Articles
    Ebooks
  • Articles
    Academic
    Ebooks
  • Info
    Home
    Subject
    Submit
    About
    News
    Submission Guide
    Contact Us
    Personality Tests
  • Login/sign up
    Login
    Register

Genetics

Advancing the Frontiers of Genetic Research — Publish and Share Your Discoveries

Register to submit your paper, and Start Earning from your Research Articles

Genetics stands at the heart of modern science—unlocking the blueprint of life through the study of genes, chromosomes, and inheritance. From foundational discoveries in Mendelian genetics by Gregor Mendel to cutting-edge developments in genomic engineering, the field of genetics continues to shape medicine, agriculture, identity, and evolution.

Today’s researchers are delving deeper than ever into the complexities of genetic genes and their interactions. Whether you're exploring dihybrid inheritance, epistatic traits, or mapping the Sry gene linked to sex determination, the possibilities for discovery are vast. The growing understanding of autosomal dominant and recessive gene traits, alongside detailed analysis of chromosomes in humans, offers vital insights into hereditary disorders and human biology.

Our platform invites researchers across all domains of genetic research—from gene sequencing and genomics to DNA testing and chromosomal studies—to publish their findings with zero publication fees. We enable you to reach a global scientific audience and earn proportional revenue through a fair and transparent monetization model. Your work remains open, visible, and impactful.

From Fundamental Inheritance to Modern Applications

Our understanding of inheritance has come a long way from simple pea plant experiments. Researchers today analyze everything from the influence of the MTHFR gene on metabolism to the role of recessive mutations in rare diseases. Studies in mendelian inheritance continue to guide diagnostics and therapy, while broader genomic approaches now inform cancer treatment, neurological research, and even personalized nutrition.

Breakthroughs in DNA testing at home have democratized access to genetics, with increasing public interest in paternity DNA testing and ancestry DNA testing. As this data pool grows, so does the responsibility and opportunity for researchers to analyze, interpret, and guide ethical genetic exploration.

Why Publish with Us?

We believe that open access to research drives progress. Our platform is designed for scientists and academics who want to share their work without barriers. Unlike traditional journals, we publish all submissions free of charge and help you monetize your content, so you can receive recognition and revenue from your research.

Whether you’re analyzing GMO’s, decoding chromosomal abnormalities, or developing tools for large-scale gene sequencing, your work belongs in a community that values both scientific rigor and accessibility.

Genetics Papers

Biomedical

Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature

Lindsay Carlsson,

Lindsay Carlsson

NULL

Emily Thain,

Emily Thain

NULL

Brittany Gillies,

Brittany Gillies

NULL

Kelly Metcalfe

Kelly Metcalfe

NULL


Introduction Knowledge of the genetic mechanisms driving hereditary breast and ovarian cancer (HBOC) has recently expanded due to advances in gene sequencing technologies. Genetic testing for HBOC risk now involves multi-gene panel testing, which includes well characterized high-penetrance genes (e.g. BRCA1 and BRCA2, as well as moderate- and low-penetrance genes. Certain moderate...
8 months ago

Biomedical

Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO

Trevor L. Hoffman,

Trevor L. Hoffman

NULL

Hilary Kershberg,

Hilary Kershberg

NULL

John Goff,

John Goff

NULL

Kimberly J. Holmquist,

Kimberly J. Holmquist

NULL

Reina Haque,

Reina Haque

NULL

Monica Alvarado

Monica Alvarado

NULL


Variants in hereditary cancer risk genes are frequently identified following tumor-based DNA sequencing and represent an opportunity to diagnose hereditary cancer. We implemented an automated hereditary cancer screening program in a large HMO for all patients who underwent tumor-based DNA sequencing to identify patients with hereditary cancer and determine if this approach augmented existing genet...
8 months ago

Biomedical

Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline

Michelle Jacobson,

Michelle Jacobson

NULL

Nadia Coakley,

Nadia Coakley

NULL

Marcus Bernardini,

Marcus Bernardini

NULL

Kelly-Ann Branco,

Kelly-Ann Branco

NULL

Laurie Elit,

Laurie Elit

NULL

Sarah Ferguson,

Sarah Ferguson

NULL

Raymond Kim

Raymond Kim

NULL


Objective The purpose of this guideline is to make recommendations regarding the care of women who harbour a pathogenic or likely pathogenic variant in BRCA1 and BRCA2 Methods Draft recommendations were formulated based on evidence obtained through a systematic review of RCTs, comparative retrospective studies and guideline endorsement. Th...
8 months ago

Biomedical

Could fumarate hydratase germline mutation in cutaneous leiomyomas predict Hereditary Leiomyoma and Renal Cell Cancer (HLRCC)?

Fu-Rong You,

Fu-Rong You

NULL

Hui-Jun Lai,

Hui-Jun Lai

NULL

Lan Yang,

Lan Yang

NULL

Hong-Wei Guo

Hong-Wei Guo

NULL


Summary

Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a genetic syndrome characterized by the development of cutaneous leiomyomas, uterine fibroids, and an increased risk of renal cell carcinoma. A recent study by You et al. explored the potential predictive value of fumarate hydratase (FH) germline mutations in cutaneous leiomyo...
8 months ago

Biomedical

Genetic testing for hereditary breast cancer in Poland: 1998–2022

Jacek Gronwald,

Jacek Gronwald

NULL

Cezary Cybulski,

Cezary Cybulski

NULL

Tomasz Huzarski,

Tomasz Huzarski

NULL

Anna Jakubowska,

Anna Jakubowska

NULL

Tadeusz Debniak,

Tadeusz Debniak

NULL

Marcin Lener,

Marcin Lener

NULL

Steven A Narod,

Steven A Narod

NULL

Jan Lubinski

Jan Lubinski

NULL


BRCA1 and BRCA2 mutations contribute to both breast cancer and ovarian cancer worldwide. In Poland approximately 4% of patients with breast cancers and 10% of patients with ovarian cancer carry a mutation in BRCA1. The majority of mutations consist of three founder mutations. A rapid inexpensive test for these three mutations can be used to screen all Polish adults at a reasonable cost. In the reg...
8 months ago

Biomedical

Beyond the pill: contraception and the prevention of hereditary ovarian cancer

Yue Yin Xia,

Yue Yin Xia

NULL

Joanne Kotsopoulos

Joanne Kotsopoulos

NULL


BRCA1 and BRCA2 mutation carriers face an elevated lifetime risk of developing ovarian cancer. Oral contraceptives have been shown to significantly decrease the risk of ovarian cancer by approximately 50% in this high-risk population. Changes in contraceptive formulations and patterns of use over time have introduced lower hormonal dosages, different steroid types and non-oral routes of administra...
8 months ago

Biomedical

Genetic susceptibility to hereditary non-medullary thyroid cancer

Tina Kamani,

Tina Kamani

NULL

Parsa Charkhchi,

Parsa Charkhchi

NULL

Afshan Zahedi,

Afshan Zahedi

NULL

Mohammad R. Akbari

Mohammad R. Akbari

NULL


Non-medullary thyroid cancer (NMTC) is the most common type of thyroid cancer. With the increasing incidence of NMTC in recent years, the familial form of the disease has also become more common than previously reported, accounting for 5–15% of NMTC cases. Familial NMTC is further classified as non-syndromic and the less common syndromic FNMTC. Although syndromic NMTC has well-known genetic risk...
8 months ago

Related Subjects

Anatomy Biochemistry Epidemiology Neuroscience Psychology Oncology Medicine Musculoskeletal science Pediatrics Pathology Pharmacology Physiology Psychiatry Primary care Women and reproductive health

Showing Page 2 to 2

  • ‹
  • 1
  • 2
  • ›

Follow Us

  • Xicon
  • Contact Us
  • Privacy Policy
  • Terms and Conditions

5 Braemore Court, London EN4 0AE, Telephone +442082758777

© Copyright 2025 All Rights Reserved.